145 related articles for article (PubMed ID: 2897104)
1. c-Ha-ras-1 polymorphism in human breast carcinomas: evidence for a normal distribution of alleles.
Sheng ZM; Guerin M; Gabillot M; Spielmann M; Riou G
Oncogene Res; 1988 Feb; 2(3):245-50. PubMed ID: 2897104
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
3. [Frequency and rearrangements of alleles of proto-oncogene c-Ha-ras-1 and their association with development of various malignant tumors in man].
Nikiforova IF; Serova OM; Pluzhnikova GF; Kniazev PG; Seĭts IF
Genetika; 1990 Mar; 26(3):531-40. PubMed ID: 1972367
[TBL] [Abstract][Full Text] [Related]
4. Evidence against Ha-ras-1 involvement in sporadic and familial melanoma.
Gerhard DS; Dracopoli NC; Bale SJ; Houghton AN; Watkins P; Payne CE; Greene MH; Housman DE
Nature; 1987 Jan 1-7; 325(6099):73-5. PubMed ID: 2879249
[TBL] [Abstract][Full Text] [Related]
5. Restriction fragment length polymorphism and activation of c-Ha-ras gene in urothelial cancer.
Ishikawa J; Maeda S; Kamidono S; Sugiyama T
Anticancer Res; 1988; 8(5A):915-24. PubMed ID: 2902823
[TBL] [Abstract][Full Text] [Related]
6. [Restriction polymorphism of the proto-oncogene c-Ha-ras-1 in patients with multiple primary malignant neoplasms and non-small-cell lung cancer].
Gaspar'ian AV; Sel'chuk VIu; Iakubovskaia MG; Zborovskaia IB; Tatosian AG
Genetika; 1997 Jan; 33(1):96-100. PubMed ID: 9162692
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of the association of inherited predisposition to breast cancer with c-Ha-ras-1 oncogene alleles].
Nefedov MD; Gar'kavtsev IV; Rogaev EI
Genetika; 1990 Dec; 26(12):2226-31. PubMed ID: 2086347
[TBL] [Abstract][Full Text] [Related]
8. Distribution and rearrangements of alleles of c-Ha-ras-1 protooncogene and their correlation with the development of lung, ovarian and thyroid cancers.
Knyazev PG; Nikiforova IF; Serova OM; Pluzhnikova GF
Neoplasma; 1990; 37(6):647-55. PubMed ID: 1980342
[TBL] [Abstract][Full Text] [Related]
9. Loss of a c-H-ras-1 allele and aggressive human primary breast carcinomas.
Theillet C; Lidereau R; Escot C; Hutzell P; Brunet M; Gest J; Schlom J; Callahan R
Cancer Res; 1986 Sep; 46(9):4776-81. PubMed ID: 3524819
[TBL] [Abstract][Full Text] [Related]
10. A single point mutation responsible for c-mos polymorphism in cancer patients.
Lidereau R; Cole ST; Larsen CJ; Mathieu-Mahul D
Oncogene; 1987 May; 1(2):235-7. PubMed ID: 2894001
[TBL] [Abstract][Full Text] [Related]
11. [Loss of Ha-ras alleles in DNA from gastric carcinoma tissue of Chinese individuals].
Shan X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Jun; 13(3):171-5. PubMed ID: 1678994
[TBL] [Abstract][Full Text] [Related]
12. c-Ha-ras polymorphism in patients with hepatocellular carcinoma. Comparison of healthy subjects and alcoholic patients with cirrhosis.
Thelu MA; Zarski JP; Froissart B; Rachail M; Seigneurin JM
Gastroenterol Clin Biol; 1993; 17(12):903-7. PubMed ID: 7907302
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the estrogen receptor gene structure in human breast cancer.
Koh EH; Ro J; Wildrick DM; Hortobagyi GN; Blick M
Anticancer Res; 1989; 9(6):1841-5. PubMed ID: 2576351
[TBL] [Abstract][Full Text] [Related]
14. [Genetic polymorphism and susceptibility to cancer].
Larsen CJ
Nouv Rev Fr Hematol (1978); 1988; 30(1-2):39-43. PubMed ID: 2898751
[TBL] [Abstract][Full Text] [Related]
15. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.
Damin AP; Frazzon AP; Damin DC; Roehe A; Hermes V; Zettler C; Alexandre CO
Cancer Detect Prev; 2006; 30(6):523-9. PubMed ID: 17113725
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor expression in human breast cancer associated with an estrogen receptor gene restriction fragment length polymorphism.
Hill SM; Fuqua SA; Chamness GC; Greene GL; McGuire WL
Cancer Res; 1989 Jan; 49(1):145-8. PubMed ID: 2562795
[TBL] [Abstract][Full Text] [Related]
17. [Amplification, rearrangement and expression of the c-myc and c-Ha-ras1 proto-oncogenes in patients with breast cancer].
Nikiforova IF
Eksp Onkol; 1988; 10(1):17-20. PubMed ID: 3286221
[TBL] [Abstract][Full Text] [Related]
18. Study of the c-Ha-ras-1 locus polymorphism in an Italian population with high incidence of gastric cancer.
Ranzani GN; Salerno-Mele P; Maltoni M; Talarico D; Della Valle G; Amadori D
Mol Biol Med; 1988 Dec; 5(3):145-53. PubMed ID: 2907601
[TBL] [Abstract][Full Text] [Related]
19. [Joint amplification of c-myc and c-Ha-ras oncogenes in human breast and thyroid cancer cells].
Pluzhnikova GF; Serova OM; Kniazev PG; Fedorov SN; Novikov LB
Eksp Onkol; 1987; 9(2):15-7. PubMed ID: 3034547
[TBL] [Abstract][Full Text] [Related]
20. MDR1 C3435T polymorphism in patients with breast cancer.
Turgut S; Yaren A; Kursunluoglu R; Turgut G
Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
